TWD 67.3
(2.75%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.90 TWD | -57.75% |
2022 | 2.13 TWD | 61.36% |
2021 | 1.32 TWD | 266.67% |
2020 | 0.36 TWD | -82.61% |
2019 | 2.07 TWD | 0.49% |
2018 | 2.06 TWD | 57.25% |
2017 | 1.31 TWD | 0.77% |
2016 | 1.30 TWD | 22.64% |
2015 | 1.06 TWD | 49.3% |
2014 | 0.71 TWD | 136.67% |
2013 | 0.30 TWD | 138.96% |
2012 | -0.77 TWD | -20.31% |
2011 | -0.64 TWD | 8.57% |
2010 | -0.70 TWD | -800.0% |
2009 | 0.10 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.23 TWD | -54.9% |
2024 Q1 | 0.51 TWD | 45.71% |
2023 Q4 | 0.35 TWD | 291.5% |
2023 FY | - TWD | -57.75% |
2023 Q1 | 0.26 TWD | 123.21% |
2023 Q2 | 0.20 TWD | -23.08% |
2023 Q3 | 0.09 TWD | -55.3% |
2022 Q1 | 0.46 TWD | 1066.39% |
2022 Q3 | 0.91 TWD | -51.6% |
2022 Q4 | -1.12 TWD | -223.08% |
2022 FY | - TWD | 61.36% |
2022 Q2 | 1.88 TWD | 308.7% |
2021 Q3 | 0.77 TWD | -20.62% |
2021 Q4 | -0.05 TWD | -106.18% |
2021 FY | - TWD | 266.67% |
2021 Q1 | -0.32 TWD | -161.54% |
2021 Q2 | 0.97 TWD | 403.13% |
2020 Q4 | 0.52 TWD | 1400.0% |
2020 Q1 | 0.01 TWD | -98.66% |
2020 Q3 | -0.04 TWD | 60.0% |
2020 FY | - TWD | -82.61% |
2020 Q2 | -0.10 TWD | -1110.1% |
2019 FY | - TWD | 0.49% |
2019 Q4 | 0.74 TWD | 208.33% |
2019 Q1 | 0.51 TWD | -57.5% |
2019 Q3 | 0.24 TWD | -60.0% |
2019 Q2 | 0.60 TWD | 17.65% |
2018 Q1 | 0.07 TWD | -67.14% |
2018 FY | - TWD | 57.25% |
2018 Q4 | 1.20 TWD | 313.79% |
2018 Q3 | 0.29 TWD | -44.23% |
2018 Q2 | 0.52 TWD | 653.62% |
2017 Q1 | 0.50 TWD | -47.37% |
2017 Q2 | 0.22 TWD | -56.0% |
2017 Q3 | 0.38 TWD | 72.73% |
2017 FY | - TWD | 0.77% |
2017 Q4 | 0.21 TWD | -44.74% |
2016 Q2 | 0.07 TWD | 2.77% |
2016 Q4 | 0.95 TWD | 352.38% |
2016 Q3 | 0.21 TWD | 214.37% |
2016 FY | - TWD | 22.64% |
2016 Q1 | 0.06 TWD | -85.56% |
2015 FY | - TWD | 49.3% |
2015 Q4 | 0.45 TWD | 0.0% |
2015 Q3 | 0.45 TWD | 387.01% |
2015 Q2 | 0.09 TWD | 1.65% |
2015 Q1 | 0.09 TWD | -62.13% |
2014 Q2 | 0.11 TWD | 0.0% |
2014 FY | - TWD | 136.67% |
2014 Q1 | 0.11 TWD | -8.33% |
2014 Q4 | 0.24 TWD | 0.0% |
2014 Q3 | 0.24 TWD | 118.18% |
2013 Q3 | 0.12 TWD | 442.99% |
2013 Q4 | 0.12 TWD | 0.0% |
2013 FY | - TWD | 138.96% |
2013 Q1 | 0.03 TWD | 111.77% |
2013 Q2 | 0.02 TWD | -14.67% |
2012 FY | - TWD | -20.31% |
2012 Q3 | -0.22 TWD | 0.0% |
2012 Q4 | -0.22 TWD | 0.0% |
2012 Q2 | - TWD | 0.0% |
2011 Q4 | - TWD | 0.0% |
2011 FY | - TWD | 8.57% |
2011 Q2 | - TWD | 0.0% |
2010 FY | - TWD | -800.0% |
2010 Q4 | - TWD | 0.0% |
2009 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Apex Biotechnology Corp. | 1.16 TWD | 22.414% |
Sinphar Pharmaceutical Co.,Ltd. | 2.24 TWD | 59.821% |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 3.42 TWD | 73.684% |
GenMont Biotech Incorporation | 0.38 TWD | -136.842% |
Abnova (Taiwan) Corporation | 0.72 TWD | -25.0% |
Adimmune Corporation | -1.52 TWD | 159.211% |
Tanvex BioPharma, Inc. | -16.42 TWD | 105.481% |
Polaris Group | -2.12 TWD | 142.453% |
Energenesis Biomedical CO.,LTD. | -3.62 TWD | 124.862% |
UnicoCell Biomed Co., Ltd. | -1.56 TWD | 157.692% |
PELL Bio-Med Technology Co. Ltd. | -8.62 TWD | 110.441% |